Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

Clinical trial NCT05093504 · TERMINATED

Trial details

NCT number: NCT05093504
Sponsor: CytoSorbents, Inc
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hemorrhage, Surgical Hemorrhage Postoperative Blood Loss, Surgical Blood Loss, Postoperative

Start date: 2021-12-27
Primary completion: 2024-01-29
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.